Please assess the completion status of the following clinical trial:

Trial Title: Use of IMSI in Poor Responders to IVF

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* poor ovarian response~Exclusion Criteria:~* body mass index (BMI) ≥ 30 kg/m2~* presence of endocrinopathies (e.g., diabetes, hyperprolactinemia, hypothyroidism)~* altered karyotype or documented genetic defects in one or both partners~* history of chronic, autoimmune or metabolic diseases~* altered meiosis in testicular biopsy or altered sperm-FISH~* teratozoospermia~* participation, simultaneously or within the previous 6 months, in another clinical trial with medication

- Gender: FEMALE
- Minimum Age: 37 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Intra-cytoplasmic Morphologically-selected Sperm Injection (IMSI)
- Control (Type: ACTIVE_COMPARATOR): Intracytoplasmic sperm injection (ICSI)

Based on this trial design, predict the completion outcome and termination type (if applicable).